Medical Stocks Worth Watching – July 15th

UnitedHealth Group, Eli Lilly and Company, and Verona Pharma PLC American Depositary Share are the three Medical stocks to watch today, according to MarketBeat’s stock screener tool. Medical stocks are shares of publicly traded companies operating within the healthcare sector, including pharmaceuticals, biotechnology, medical devices and healthcare services. By purchasing these shares, investors gain an ownership stake in firms that research, develop or deliver medical products and treatments. The performance of medical stocks often hinges on factors like regulatory approvals, clinical trial results and broader industry trends. These companies had the highest dollar trading volume of any Medical stocks within the last several days.

UnitedHealth Group (UNH)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

UNH stock traded down $6.34 during trading on Tuesday, hitting $294.24. The company had a trading volume of 8,728,592 shares, compared to its average volume of 7,722,144. The stock has a market cap of $266.92 billion, a PE ratio of 12.32, a PEG ratio of 1.46 and a beta of 0.45. The business has a 50-day moving average of $312.43 and a 200-day moving average of $438.47. UnitedHealth Group has a one year low of $248.88 and a one year high of $630.73. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71.

Eli Lilly and Company (LLY)

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.

NYSE LLY traded down $20.33 during trading hours on Tuesday, hitting $779.01. The company had a trading volume of 2,225,852 shares, compared to its average volume of 3,794,403. The firm has a 50 day simple moving average of $765.95 and a 200 day simple moving average of $800.18. Eli Lilly and Company has a 52 week low of $677.09 and a 52 week high of $972.53. The firm has a market capitalization of $738.29 billion, a price-to-earnings ratio of 63.41, a PEG ratio of 1.16 and a beta of 0.40. The company has a debt-to-equity ratio of 2.18, a quick ratio of 1.06 and a current ratio of 1.37.

Verona Pharma PLC American Depositary Share (VRNA)

Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodilator and an anti-inflammatory agent in a single compound, which is in Phase 3 clinical trials for the treatment of chronic obstructive pulmonary disease, asthma, and cystic fibrosis.

Shares of NASDAQ VRNA traded up $0.17 during mid-day trading on Tuesday, hitting $104.84. 8,245,239 shares of the stock traded hands, compared to its average volume of 1,676,478. Verona Pharma PLC American Depositary Share has a 52 week low of $18.51 and a 52 week high of $104.99. The stock has a fifty day moving average price of $84.54 and a 200-day moving average price of $68.38. The company has a debt-to-equity ratio of 1.07, a quick ratio of 8.73 and a current ratio of 8.86. The company has a market cap of $8.92 billion, a price-to-earnings ratio of -52.42 and a beta of 0.24.